| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Announcement
|
|
|
2019
|
|
supplement-1 |
p. 1
|
artikel
|
| 2 |
Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms
|
Reginster, Jean-Yves
|
|
2019
|
|
supplement-1 |
p. 3-6
|
artikel
|
| 3 |
Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
|
Honvo, Germain
|
|
2019
|
|
supplement-1 |
p. 145-159
|
artikel
|
| 4 |
Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
|
Curtis, Elizabeth
|
|
2019
|
|
supplement-1 |
p. 25-44
|
artikel
|
| 5 |
Safety of Intra-articular Hyaluronic Acid Injections in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
|
Honvo, Germain
|
|
2019
|
|
supplement-1 |
p. 101-127
|
artikel
|
| 6 |
Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
|
Fuggle, Nicholas
|
|
2019
|
|
supplement-1 |
p. 129-143
|
artikel
|
| 7 |
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
|
Cooper, Cyrus
|
|
2019
|
|
supplement-1 |
p. 15-24
|
artikel
|
| 8 |
Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?
|
Conaghan, Philip G.
|
|
2019
|
|
supplement-1 |
p. 7-14
|
artikel
|
| 9 |
Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
|
Honvo, Germain
|
|
2019
|
|
supplement-1 |
p. 65-99
|
artikel
|
| 10 |
Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
|
Honvo, Germain
|
|
2019
|
|
supplement-1 |
p. 45-64
|
artikel
|
Tijdschrift beschrijving